Healthcare diagnostics company QuidelOrtho NASDAQ:QDELwill be reporting earnings this Thursday after the bell. Here’s what to expect.QuidelOrtho missed analysts’ revenue expectations last quarter, reporting revenues of $619.8 million, down 10.5% year on year. It was a softer quarter for the company…
(14:30 GMT) QuidelOrtho Price Target Raised to $12.00/Share From $11.00 by JP Morgan
What Happened? Shares of healthcare diagnostics company QuidelOrtho NASDAQ:QDELjumped 34.7% in the afternoon session after reports revealed that the company is considering the sale of its point-of-care testing business for about $1.5 billion.According to reports, QuidelOrtho is evaluating bids from…
Shares of QuidelOrtho Corporation (QDEL) rocketed 35% on Monday after reports that the diagnostics company is exploring the sale of its point-of-care testing business at a valuation of around $1.5 billion.The stock is now on track for its best day since May 2025, if gains hold.QDEL Explores Sale Fo…
-- Source link: https://tinyurl.com/3w7dfnsc-- Note: Reuters has not verified this story and does not vouch for its accuracy
